Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron ® europe
… involved analyzing patient health outcomes based on physician prescription patterns in patients with type 2 …
… the US FDA has advocated for including patients’ voice in drug development and has issued new guidelines on how to do …
… regulatory focus on incorporating patient perspectives in drug development, patient-reported outcomes, known as PROs, …
… claims database analyses, cross-sectional and longitudinal survey analyses, econometric modeling, and data management … Additionally, Dr. Candrilli has analyzed numerous survey databases (including the National Health and Nutrition … Expenditure Panel Survey, and the Healthcare Cost and Utilization Project family of databases) to estimate the …
… epidemiologic support for the preparation of orphan drug applications and other key regulatory submissions in the US and Europe, targeted and systematic literature reviews, and …
… in a collaborative Consortium with 15 research partners in Europe. “This project will represent a coordinated effort by …
… among patients with HR+/HER2− advanced breast cancer in Europe. Oikonomidou O, Galve-Calvo E, Wockel A, Parikh R, …
How are United States ICER'S Evidence Ratings Determined? You can read the related research here: How are United States ICER'S evidence ratings determined?: A systematic review of ICER'S evidence ratings in evidence reports for new drugs in 2020 and 2021. …
RTI receives Cigna Healthy Workforce Designation ™ Share on: March 3, 2023 Image Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation …
… of transitions to later stages of Alzheimer's disease in Europe: elevating the sense of urgency to treat. Razavi M, …